Lunai Bioworks Inc. Operating Leases, Future Minimum Payments, Due in Four Years
Lunai Bioworks Inc. (LNAI) had Operating Leases, Future Minimum Payments, Due in Four Years of $260.99 thousand as of 2023-03-31, per its 10-Q filed 2023-05-12.
Discontinued › Notes › Leases
us-gaap:OperatingLeasesFutureMinimumPaymentsDueInFourYears · last filed 2023-05-12
- 2023-03-31: Operating Leases, Future Minimum Payments, Due in Four Years $260.99K.
- 2022-12-31: Operating Leases, Future Minimum Payments, Due in Four Years $260.99K.
- 2022-09-30: Operating Leases, Future Minimum Payments, Due in Four Years $260.99K.
- 2022-06-30: Operating Leases, Future Minimum Payments, Due in Four Years $260.99K.
| Period end | Operating Leases, Future Minimum Payments, Due in Four Years | Operating Leases, Future Minimum Payments, Due in Four Years as first filed |
|---|---|---|
| 2023-03-31 | $260.99K 10-Q · filed 2023-05-12 | |
| 2022-12-31 | $260.99K 10-Q · filed 2023-03-09 | |
| 2022-09-30 | $260.99K 10-Q · filed 2023-03-07 | |
| 2022-06-30 | $260.99K 10-K · filed 2023-02-27 | |
| 2022-03-31 | $253.38K 10-Q · filed 2022-05-13 | |
| 2021-12-31 | $253.38K 10-Q · filed 2022-02-14 | |
| 2021-09-30 | $253.38K 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $253.38K 10-K · filed 2021-09-24 | |
| 2021-03-31 | $253.38K 10-Q · filed 2021-05-17 | |
| 2020-12-31 | $253.38K 10-Q · filed 2021-02-16 | |
| 2020-09-30 | $246.00K 10-Q · filed 2020-11-12 | |
| 2020-06-30 | $246.00K 10-K · filed 2020-09-23 | |
| 2020-03-31 | $298.31K 10-Q · filed 2020-05-11 | |
| 2019-12-31 | $298.31K 10-Q · filed 2020-02-10 | |
| 2019-09-30 | $298.31K 10-Q · filed 2019-11-13 | |
| 2019-06-30 | $298.31K 10-K · filed 2019-09-30 | |
| 2018-06-30 | $351.99K 10-Q · filed 2019-05-16 | $283.41K 10-K · filed 2018-10-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |